CELL- MEDIATED IMMUNITY IN CRYPTOCOCCOSISGRAYBILL JR; ALFORD RH.1974; CELL. IMMUNOL.; U.S.A.; DA. 1974; VOL. 14; NO 1; PP. 12-21; BIBL. 23REF.Article

ANTIFUNGAL AGENTS USED IN SYSTEMIC MYCOSES: ACTIVITY AND THERAPEUTIC USEGRAYBILL JR; CRAVEN PC.1983; DRUGS (NEW YORK); ISSN 0012-6667; USA; DA. 1983; VOL. 25; NO 1; PP. 41-62; BIBL. 5 REF.Article

VARIABILITY OF SEQUENTIAL STUDIES OF LYMPHOCYTE BLASTOGENESIS IN NORMAL ADULTSGRAYBILL JR; ALFORD RH.1976; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1976; VOL. 25; NO 1; PP. 28-35; BIBL. 27 REF.Article

HOST DEFENSE IN CRYPTOCOCCOSIS. III: IN VIVO ALTERATION OF IMMUNITYGRAYBILL JR; MITCHELL L.1979; MYCOPATHOLOGIA; NLD; DA. 1979; VOL. 69; NO 3; PP. 171-178; BIBL. 13 REF.Article

CYCLOPHOSPHAMIDE EFFECTS ON MURINE CRYPTOCOCCOSISGRAYBILL JR; MITCHELL L.1978; INFECT. AND IMMUN.; USA; DA. 1978; VOL. 21; NO 2; PP. 674-677; BIBL. 10 REF.Article

SUCCESSFUL TREATMENT OF CRYPTOCOCCAL MENINGITIS WITH INTRAVENTRICULAR MICONAZOLE.GRAYBILL JR; LEVINE HB.1978; ARCH. INTERN. MED.; U.S.A.; DA. 1978; VOL. 138; NO 5; PP. 814-816; BIBL. 14 REF.Article

PASSIVE IMMUNIZATION IN MURINE CRYPTOCOCCOSISGRAYBILL JR; HAGUE M; DRUTZ DJ et al.1981; SABOURAUDIA; ISSN 0036-2174; GBR; DA. 1981; VOL. 19; NO 4; PP. 237-244; ABS. FRE; BIBL. 17 REF.Article

ADOPTIVE TRANSFER OF IMMUNITY TO HISTOPLASMA CAPSULATUM IN ATHYMIC NUDE MICEWILLIAMS DM; GRAYBILL JR; DRUTZ DJ et al.1981; SABOURAUDIA; ISSN 0036-2174; GBR; DA. 1981; VOL. 19; NO 1; PP. 39-48; ABS. FRE; BIBL. 11 REF.Article

EXPERIMENTAL CHEMOTHERAPY OF HISTOPLASMOSIS IN NUDE MICEWILLIAMS DM; GRAYBILL JR; DRUTZ DJ et al.1979; AMER. REV. RESP. DIS.; USA; DA. 1979; VOL. 120; NO 4; PP. 837-842; BIBL. 15 REF.Article

PULMONARY CRYPTOCOCCOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA = CRYPTOCOCCOSE PULMONAIRE DANS LA LEUCEMIE LYMPHOIDE CHRONIQUEWHITLEY TH; GRAYBILL JR; ALFORD RH et al.1976; SOUTH. MED. J.; U.S.A.; DA. 1976; VOL. 69; NO 1; PP. 33-36; BIBL. 15 REF.Article

TISSUE ANTIBIOTIC PENETRATION IN STREPTO COCCAL GANGRENE = PENETRATION TISSULAIRE DES ANTIBIOTIQUES DANS LA GANGRENE STREPTOCOCCIQUEGRAYBILL JR; PIERSON DN; CHARACHE P et al.1973; JOHNS HOPKINS MED. J.; U.S.A.; DA. 1973; VOL. 133; NO 1; PP. 45-50; BIBL. 17 REF.Article

TREATMENT OF MURINE CRYPTOCOCCOSIS WITH LIPOSOME-ASSOCIATED AMPHOTERICIN BGRAYBILL JR; CRAVEN PC; TAYLOR RL et al.1982; J. INFECT. DIS.; ISSN 0022-1899; USA; DA. 1982; VOL. 145; NO 5; PP. 748-752; BIBL. 9 REF.Conference Paper

SUPPRESSION OF CRYPTICOCCOSIS AND HISTOPLASMOSIS BY KETOCONAZOLE IN ATHYMIC NUDE MICEWILLIAMS DM; GRAYBILL JR; DRUTZ DJ et al.1980; J. INFECT. DIS.; USA; DA. 1980; VOL. 141; NO 1; PP. 76-80; BIBL. 14 REF.Article

IMMUNOGENIC FRACTIONS OF CRYPTOCOCCUS NEOFORMANSGRAYBILL JR; STRAUS DC; NEALON TJ et al.1982; MYCOPATHOLOGIA (1975); ISSN 0301-486X; NLD; DA. 1982; VOL. 78; NO 1; PP. 31-39; BIBL. 20 REF.Article

HISTOPLASMIN-CYL, A YEAST PHASE REAGENT IN SKIN TEST STUDIES WITH HUMANSLEVINE HB; SCALARONTE GM; CAMPBELL GD et al.1979; AMER. REV. RESP. DIS.; USA; DA. 1979; VOL. 119; NO 4; PP. 629-636; BIBL. 17 REF.Article

TREATMENT OF SYSTEMIC MYCOSES WITH KETOCONAZOLE: EMPHASIS ON TOXICITY AND CLINICAL RESPONSE IN 52 PATIENTS. NATIONAL INSTITUTE OF ALLERGY AND INFECTIONS DISEASES COLLABORATIVE ANTIFUNGAL STUDYDISMUKES WE; STAMM AM; GRAYBILL JR et al.1983; ANNALS OF INTERNAL MEDICINE; ISSN 0003-4819; USA; DA. 1983; VOL. 98; NO 1; PP. 13-20; BIBL. 30 REF.Article